Chronic Hepatitis C

Google_______________
Rebetol (ribavirin) / Copegus (ribavirin) / Generic Ribavirin
Weight-based Ribavirin - Articles

Does Weight-based Ribavirin Dosing Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study - 11/18/05
The Effect of Ribavirin on Bone Density in Children with Chronic Hepatitis C Treated with Interferon-Ribavirin - 11/07/05
The Doctor is in Q and A: Ribavirin and Pregnancy - 7/25/05
Efficacy of Ribavirin Monotherapy Following Combination Therapy with Interferon Alfa-2b (Intron A) and Ribavirin in Patients with Chronic Hepatitis C - 6/10/05
Double-dose Peginterferon Alfa-2b Plus Weight-based Ribavirin for Retreatment of African-American Non-Responders with Hepatitis C   - 5/18/05
Liver Fibrosis Progression Is Accelerated in Renal Transplant Patients Receiving Ribavirin Monotherapy for Chronic Hepatitis C - 3/30/05
Ribavirin Plays Critical Role in the Response to Peginterferon-based Anti-HCV Therapy - 2/28/05
Nine of 10 Chronic Hepatitis C Patients Achieve a Cure 24 Weeks Post-treatment with High Dose Ribavirin Plus Standard Dose Peginterferon Alfa-2a (Pegasys) - 2/11/05
Treatment of Established Recurrent Hepatitis C in Liver Transplant Recipients with Pegylated Interferon Alfa-2b and Ribavirin Therapy - 1/14/05
Researcher Cites “Potential Bias" Toward Peg Intron in New Trial - 1/12/05
Researcher Cites “Potential Bias" Toward Peg Intron in New Trial - 1/12/05

Hematologic Side Effects of Interferon and Ribavirin Therapy - 1/10/05

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS
| INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US